CG
WST icon

Clinton Group’s West Pharmaceutical WST Stock Holding History

Clinton Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-13,835
Closed -$1.31M – 625
2017
Q2 		$1.31M Sell
13,835
-15,623
-53% -$1.44M 0.13% 243
2017
Q1 		$2.4M Buy
+29,458
New +$2.46M 0.14% 214
2016
Q3 		– Sell
-14,694
Closed -$1.11M – 1089
2016
Q2 		$1.11M Buy
+14,694
New +$1.07M 0.05% 447
2014
Q4 		– Sell
-5,220
Closed -$234K – 578
2014
Q3 		$234K Sell
5,220
-10,426
-67% -$443K 0.09% 309
2014
Q2 		$660K Sell
15,646
-477
-3% -$20.4K 0.33% 79
2014
Q1 		$710K Buy
+16,123
New +$759K 0.26% 90

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Clinton Group's WST Position: Q3 2017 in Review

Clinton Group sold out of West Pharmaceutical (WST) in Q3 2017, closing a stake of 13,835 shares — an estimated $1.31M sold.

Clinton Group first reported a position in WST in Q1 2014 and held it in 6 quarters. The position peaked at $2.4M in Q1 2017. 302 funds tracked by Wall St. Rank hold WST as of Q3 2017.

  • Clinton Group reported no remaining West Pharmaceutical position as of Q3 2017 after selling out during the quarter.
  • Clinton Group sold 13,835 West Pharmaceutical shares in Q3 2017, an estimated $1.31M.
  • Clinton Group first reported a position in West Pharmaceutical in Q1 2014 and held it in 6 quarters.
  • Clinton Group's West Pharmaceutical position peaked at $2.4M in Q1 2017.
  • 302 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2017.

Based on Clinton Group's 13F filing for Q3 2017, filed 14 Nov 2017.